Medisafe Demonstrates Multi Month Adherence Lift In Study By Ims Health

Medisafe Demonstrates Multi Month Adherence Lift In Study By Ims Health Medisafe, the leading mhealth platform for medication management with over 2.3 million users, announced today the results of a study conducted by ims health that showed that medisafe users taking cholesterol, hypertension and diabetes medication had 10.7%, 5.4%, and 7.7% higher adherence respectively than a control group of non users over a. Boston, oct. 29, 2015 prnewswire medisafe, the leading mhealth platform for medication management with over 2.3 million users, announced today the results of a study conducted by ims health.

Medisafe Platform App Increase Medication Adherence Medisafe The study shows that medisafe users taking cholesterol lowering or anti hypertension medication had an improved persistence compared to matching control groups. the relative increase in adherence over six months was 8.4% for anti hypertension patient users and 19.5% for hyperlipidemia patient users. results demonstrated a statistically. Medication non adherence remains to be a leading public health problem in the united states, estimated to cause 125,000 deaths annually.1 medisafe collaborated with ims health to conduct a study evaluating medication adherence among medisafe users with hypertension, hyperlipidemia and diabetes against a control group of non users, using anonymous prescription data. research results focused on. The study looked at medisafe users taking medication to manage cholesterol and hypertension and found respective 19.5% and 8.4% increases in adherence after sixth months compared to non users. A study by medisafe and ims health showed an upward trend in medication adherence among people with chronic conditions like hyperlipidemia, hypertension, and diabetes who used its mobile.

Medisafe Improves Adherence And Lowers Costs For Chronic Disease The study looked at medisafe users taking medication to manage cholesterol and hypertension and found respective 19.5% and 8.4% increases in adherence after sixth months compared to non users. A study by medisafe and ims health showed an upward trend in medication adherence among people with chronic conditions like hyperlipidemia, hypertension, and diabetes who used its mobile. Condition itself, the health system, and the medications—can drive nonadherence (exhibit 2). 3 “medisafe demonstrates multi month adherence lift in study by ims health,” medisafe, october 29, 2015, medisafe . Medisafe is in the process of releasing several studies in partnership with iqvia, showing the impact of a digital solution on medication adherence for various therapeutic areas. these studies are available on our website and show that medisafe demonstrates double digit improvement in adherence.